These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32702128)

  • 41. No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
    Kingma A; Van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):106-14. PubMed ID: 11990695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
    Bassan R; Masciulli A; Intermesoli T; Audisio E; Rossi G; Pogliani EM; Cassibba V; Mattei D; Romani C; Cortelezzi A; Corti C; Scattolin AM; Spinelli O; Tosi M; Parolini M; Marmont F; Borlenghi E; Fumagalli M; Cortelazzo S; Gallamini A; Marfisi RM; Oldani E; Rambaldi A
    Haematologica; 2015 Jun; 100(6):786-93. PubMed ID: 25749825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytarabine-induced aseptic meningitis.
    van den Berg H; van der Flier M; van de Wetering MD
    Leukemia; 2001 Apr; 15(4):697-9. PubMed ID: 11368387
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Uchimaru K; Tojo A
    Intern Med; 2008; 47(22):1987-8. PubMed ID: 19015613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute lymphoblastic leukemia].
    Hatta Y
    Rinsho Ketsueki; 2014 Feb; 55(2):185-90. PubMed ID: 24598186
    [No Abstract]   [Full Text] [Related]  

  • 48. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
    Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
    Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
    [No Abstract]   [Full Text] [Related]  

  • 49. Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
    Minicucci EM; Lopes LF; Crocci AJ
    Leuk Res; 2003 Jan; 27(1):45-50. PubMed ID: 12479851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Attarbaschi A; Mann G; Zimmermann M; Bader P; Barisone E; Basso G; Biondi A; Cario G; Cazzaniga G; Colombini A; Flotho C; Kuhlen M; Lang P; Lauten M; Linderkamp C; Locatelli F; Lo Nigro L; Möricke A; Niggli F; Panzer-Grümayer R; Parasole R; Peters C; Caterina Putti M; Rizzari C; Suttorp M; Valsecchi MG; Conter V; Schrappe M;
    Leukemia; 2020 Jun; 34(6):1694-1700. PubMed ID: 31806872
    [No Abstract]   [Full Text] [Related]  

  • 52. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A; Ishii E; Nagatoshi Y; Eguchi H; Koga H; Yanai F; Inada H; Nibu K; Tamai Y; Akiyoshi K; Nakayama H; Hara T; Take H; Miyazaki S; Okamura J
    Int J Hematol; 2001 Apr; 73(3):369-77. PubMed ID: 11345205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 55. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
    Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A step forward in therapy for ALL in infants.
    Ribera JM; Oriol A
    Lancet; 2007 Jul; 370(9583):198-200. PubMed ID: 17658376
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
    Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
    Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of polychemotherapy on hemopoiesis in acute lymphoblastic leukemia in children].
    Vladimirskaia EB; Zamarraeva NV; Lebedev VV; Kryzhanovskiĭ OI; Rumiantsev AG; Sallakh S; Tabet S; Mazo IB
    Gematol Transfuziol; 1993 May; 38(5):6-10. PubMed ID: 8034176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate, homocysteine, and seizures.
    Quinn CT; Griener JC; Bottiglieri T; Kamen BA
    J Clin Oncol; 1998 Jan; 16(1):393-4. PubMed ID: 9440774
    [No Abstract]   [Full Text] [Related]  

  • 60. Neutrophilic eccrine hidradenitis.
    Thorisdottir K; Tomecki KJ; Bergfeld WF; Andresen SW
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):775-7. PubMed ID: 8496425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.